Skip to main content
Decorative image of the COVID-19 Learning Lounge

COVID-19 in Infants Less than 3 Months: Severe or Not Severe Disease?


This study offers a detailed look at research results about the prognosis of COVID-19 in children under 90 days old. Although severe and fatal COVID-19 cases are less common in children, a higher risk for progression has been reported in infants, particularly those with underlying medical conditions. This study utilizes data from 216 children less than 90 days old to compare symptoms, severity scoring, and clinical outcomes to previous literature. Concerns are also addressed regarding antimicrobial stewardship (AMS) and the effective treatment of symptomatic infants.


Daniele Dona, MD, PhD, MSc, Division of Pediatric Infectious Diseases, University of Padua, Italy

Carlotta Montagnani, PhD, Division of Pediatric Infectious Diseases, Anna Meyer Children’s University Hospital in Florence, Italy


Read the MDPI Viruses Journal study.

Read time: 15 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Global Solutions

COVID-19 Testing Solutions for Healthcare

Because every COVID-19 patient comes with a unique profile and experiences the disease differently, patient management means asking the right questions, finding the right answers and providing appropriate care the entire length of the patient pathway.

U.S. bioMérieux Solutions

US Solutions

BIOFIRE® Respiratory 2.1 and 2.1plus Panels

The BIOFIRE RP2.1 and RP2.1plus Panels use the syndromic approach to accurately detect and identify the pathogens most associated with respiratory infections. Fast and comprehensive results may enable better-informed diagnosis and treatment of patients.


MDPI Viruses Journal
October 14, 2022